A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and efficacy effects of two doses of
asoprisnil (10 mg and 25 mg) compared with placebo when administered daily for 6 months to
premenopausal subjects with symptomatic uterine leiomyomata.